| 1 | MTOR, TFE3, TFEB
|
| AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3
|
| Paquette M, El-Houjeiri L, C Zirden L, Puustinen P, Blanchette P, Jeong H, Dejgaard K, Siegel PM, Pause A.
|
| Autophagy. Dec;17(12):3957-3975. doi: 10.1080/15548627.2021.1898748. Epub 2021 Mar 18. 2021
|
| 2 | CDK4, CDK6, TFE3, TFEB
|
| CDK4/6 regulate lysosome biogenesis through TFEB/TFE3. 2020 PMID:
|
| Yin Q, Jian Y, Xu M, Huang X, Wang N, Liu Z, Li Q, Li J, Zhou H, Xu L, Wang Y, Yang C.
|
| J Cell Biol. Aug 3;219(8):e201911036. doi: 10.1083/jcb.201911036. 2020
|
| 3 | FNIP1, MTOR, TFE3
|
| Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3
|
| Ramírez JA, Iwata T, Park H, Tsang M, Kang J, Cui K, Kwong W, James RG, Baba M, Schmidt LS, Iritani BM.
|
| J Immunol. Dec 1;203(11):2899-2908. doi: 10.4049/jimmunol.1900395. Epub 2019 Nov 1. 2019
|
| 4 | ASPSCR1, TFE3
|
| Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
|
| Wang XT, Xia QY, Zhou XJ, Rao Q.
|
| Crit Rev Oncog. 22(5-6):481-497. doi: 10.1615/CritRevOncog.2017020558 2017
|
| 5 | CAMTA1, TFE3
|
| Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
|
| Lee SJ, Yang WI, Chung WS, Kim SK.
|
| Oncotarget 7(7):7480-8. doi: 10.18632/oncotarget.7060.
2016
|
| 6 | TFE3, YAP1
|
| Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
|
| Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, Chen HW, Pathan N, Krausz T, Dickson BC, Weinreb I, Rubin MA, Hameed M, Fletcher CD.
|
| Genes Chromosomes Cancer 52(8):775-84. doi: 10.1002/gcc.22073. Epub 2013 Jun 5.
2013
|
| 7 | ESRRB, TFE3
|
| Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3.
|
| Betschinger J, Nichols J, Dietmann S, Corrin PD, Paddison PJ, Smith A.
|
| Cell 153(2):335-47. doi: 10.1016/j.cell.2013.03.012.
2013
|
| 8 | MYOG, TFE3
|
| TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin.
|
| Naka A, Iida KT, Nakagawa Y, Iwasaki H, Takeuchi Y, Satoh A, Matsuzaka T, Ishii KA, Kobayashi K, Yatoh S, Shimada M, Yahagi N, Suzuki H, Sone H, Yamada N, Shimano H.
|
| Biochem Biophys Res Commun 430(2):664-9. doi: 10.1016/j.bbrc.2012.11.094. Epub 2012 Dec 2.
2013
|
| 9 | TFE3
|
| TFE3 Controls Lipid Metabolism in Adipose Tissue of Male Mice by Suppressing Lipolysis and Thermogenesis.
|
| Fujimoto Y, Nakagawa Y, Satoh A, Okuda K, Shingyouchi A, Naka A, Matsuzaka T, Iwasaki H, Kobayashi K, Yahagi N, Shimada M, Yatoh S, Suzuki H, Yogosawa S, Izumi T, Sone H, Urayama O, Yamada N, Shimano H.
|
| Endocrinology ndocrinology. 2013 Jul 24. [Epub ahead of print]
2013
|
| 10 | ASPSCR1, TFE3
|
| Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
|
| Kobos R, Nagai M, Tsuda M, Merl MY, Saito T, Laé M, Mo Q, Olshen A, Lianoglou S, Leslie C, Ostrovnaya I, Antczak C, Djaballah H, Ladanyi M.
|
| J Pathol. Apr;229(5):743-754. doi: 10.1002/path.4158. Epub 2013 Mar 5 2013
|
| 11 | TFE3
|
| Transcription factor E3, a major regulator of mast cell-mediated allergic response.
|
| Yagil Z, Hadad Erlich T, Ofir-Birin Y, Tshori S, Kay G, Yekhtin Z, Fisher DE, Cheng C, Wong WS, Hartmann K, Razin E, Nechushtan H.
|
| J Allergy Clin Immunol 129(5):1357-1366.e5. doi: 10.1016/j.jaci.2011.11.051. Epub 2012 Feb 22.
2012
|
| 12 | ALK, CLTC, TFE3
|
| Clathrin heavy chain gene fusions expressed in human cancers: analysis of cellular functions.
|
| Blixt MK, Royle SJ.
|
| Traffic 12(6):754-61. doi: 10.1111/j.1600-0854.2011.01183.x. Epub 2011 Mar 24.
2011
|
| 13 | MARK3, MITF, TFE3
|
| C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3.
|
| Schwarz T, Murphy S, Sohn C, Mansky KC.
|
| Biochem Biophys Res Commun 394(4):890-5. Epub 2010 Mar 7.PMID: 20214879 2010
|
| 14 | MAFB, TFE3
|
| TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation.
|
| Zanocco-Marani T, Vignudelli T, Parenti S, Gemelli C, Condorelli F, Martello A, Selmi T, Grande A, Ferrari S.
|
| Exp Cell Res 315(11):1798-808. Epub 2009 Mar 28.
2009
|
| 15 | SREBF1, TFE3
|
| SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling.
|
| Shimano H.
|
| J Mol Med 85(5):437-44. Epub 2007 Feb 6. Review.
2007
|
| 16 | TFE3
|
| Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
|
| LaGrange CA, Lele SM, Strup SE.
|
| Urology 70(3):590.e11-2.
2007
|
| 17 | TFE3, IRS2, HK2, INSIG1
|
| TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
|
| Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N.
|
| Nat Med 12(1):107-13. Epub 2005 Dec 4. 2006
|
| 18 | TFE3, TFEB
|
| Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.
|
| Huan C, Kelly ML, Steele R, Shapira I, Gottesman SR, Roman CA.
|
| Nat Immunol 7(10):1082-91. Epub 2006 Aug 27.
2006
|
| 19 | TFE3, TFEC
|
| Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors.
|
| Zanocco-Marani T, Vignudelli T, Gemelli C, Pirondi S, Testa A, Montanari M, Parenti S, Tenedini E, Grande A, Ferrari S.
|
| Exp Cell Res 312(20):4079-89. Epub 2006 Sep 22.
2006
|
| 20 | TFE3, TFEB
|
| Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin.
|
| Huan C, Sashital D, Hailemariam T, Kelly ML, Roman CA.
|
| J Biol Chem 280(34):30225-35. Epub 2005 Jun 30.
2005
|
| 21 | TFE3
|
| A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
|
| Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M.
|
| Oncogene 22(34):5374-8. 2003
|
| 22 | MITF, TFE3, TFEC
|
| The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter.
|
| Mansky KC, Sulzbacher S, Purdom G, Nelsen L, Hume DA, Rehli M, Ostrowski MC.
|
| J Leukoc Biol 71(2):304-10.
2002
|
| 23 | ASPS, ASPSCR1, TFE3
|
| The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
|
| Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Cin PD, Bridge J.
|
| Oncogene 20(1):48-57. 2001
|
| 24 | MAD2L2, PRCC, TFE3
|
| Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
|
| Weterman MA, van Groningen JJ, Tertoolen L, van Kessel AG.
|
| Proc Natl Acad Sci U S A 98(24):13808-13. 2001
|
| 25 | TFE3
|
| TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
|
| Verastegui C, Bertolotto C, Bille K, Abbe P, Ortonne JP, Ballotti R.
|
| Mol Endocrinol 14(3):449-56. 2000
|
| 26 | PRCC, TFE3
|
| Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.
|
| Weterman MAJ, et al.
|
| Proc Natl Acad Sci U S A 93 : 15294-15298. 1996
|
| 27 | PRCC, TFE3
|
| The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.
|
| Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS.
|
| Hum Mol Genet 5(9):1333-8. 1996
|
| 28 | PRCC, TFE3
|
| Molecular cloning of the papillary renal cell carcinoma-associated translocation (X;1)(p11;q21) breakpoint.
|
| Weterman MA, Wilbrink M, Janssen I, Janssen HA, van den Berg E, Fisher SE, Craig I, Geurts van Kessel A.
|
| Cytogenet Cell Genet 75(1):2-6. 1996
|
| 29 | DXS146, DXS255, TBX1, TBC1D25, SYP, TFE3
|
| Construction of two YAC contigs in human Xp11.23-p11.22, one encompassing the loci OATL1,GATA,TFE3, and SYP, the other linking DXS255 to DXS146.
|
| Fisher SE, et al.
|
| Genomics 29 : 496-502. 1995
|
| 30 | TFE3
|
| The genomic organization of the human transcription factor 3 (TFE3) gene.
|
| Macchi P, et al.
|
| Genomics 28 : 491-494. 1995
|
| 31 | SYP, TFE3
|
| Hybrid and meiotic mapping and construction of a YAC contig in the Xp11 region. (abstr)
|
| Bech-Hansen NT, et al.
|
| Cytogenet Cell Genet 67 : 358. 1994
|
| 32 | TFE3
|
| The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22.
|
| Henthorn PS, et al.
|
| Genomics 11 : 374-378. 1991
|
| 33 | TFE3
|
| A high-frequency RFLP at the human TFE3 locus on the X chromosome.
|
| Puck JM, et al.
|
| Nucleic Acids Res 19 : 684. 1991
|